Skip to main content
logo
Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
6.08
-0.02 (-0.41%)
Aug 10, 2026, 10:29 AM EDT - Market open

Wave Life Sciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
65.3742.73108.3113.313.6540.96
Revenue Growth
-30.42%-60.55%-4.42%3005.10%-91.09%104.03%
Gross Profit
65.3742.73108.3113.313.6540.96
Operating Income
-217.92-215.38-110.4-68-162.72-127.02
Net Income
-202.47-204.38-97.01-57.51-161.82-122.25
Earnings Per Share
-1.09-1.21-0.70-0.54-2.05-2.36
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
490.6602.07302.08200.3588.5150.56
Total Debt
43.5917.7725.432.1237.6129.92
Net Cash (Debt)
447.01584.3276.67168.2350.88120.65
Net Cash Growth
139.34%111.19%64.46%230.63%-57.83%-22.26%
Net Cash Per Share
2.383.462.001.590.652.33

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-191.58-187.49-151.03-19.43-127.78-88.99
Capital Expenditures
-1.57-0.72-0.94-1.12-1.36-0.56
Free Cash Flow
-193.15-188.21-151.96-20.55-129.14-89.55
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-333.36%-504.09%-101.94%-60.01%-4459.30%-310.07%
Pretax Margin
-309.73%-478.33%-89.57%-51.36%-4416.06%-298.92%
Profit Margin
-309.73%-478.34%-89.57%-50.76%-4434.72%-298.42%
FCF Margin
-295.46%-440.50%-140.31%-18.13%-3539.11%-218.61%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
18.3974.6717.484.89166.754.59